Literature DB >> 27671081

Phenotypic and genotypic profiling of antimicrobial resistance in enteric Escherichia coli communities isolated from finisher pigs in Australia.

M G Smith1, D Jordan2, J S Gibson3, R N Cobbold1, T A Chapman4, S Abraham5,6, D J Trott5.   

Abstract

OBJECTIVE: To assess herd-to-herd variation in antimicrobial resistance phenotypes and associated antimicrobial resistance genes (ARGs) in faecal commensal Escherichia coli communities isolated from Australian slaughter-age pigs.
METHODS: Hydrophobic grid-membrane filtration (HGMF) was used to screen populations of E. coli isolated from faecal samples obtained from pigs prior to or at slaughter. Multiplex PCRs were applied to the pooled DNA extracted from the samples to identify specific ARGs.
METHODS: Pooled faecal samples from 30 finishers, from 72 different Australian pig farms, produced 5003 isolates for screening. HGMF techniques and image analysis were used to confirm E. coli resistance phenotypes to four antimicrobial agents (ampicillin, gentamicin, florfenicol and ceftiofur) using selective agars. Multiplex PCRs were performed on DNA from pooled samples for 35 ARGs associated with seven chemical classes.
RESULTS: The prevalence of E. coli isolates showing no resistance to any of the drugs was 50.2% (95% confidence interval (CI) 41.8-58.6%). Ceftiofur resistance was very low (1.8%; CI 0.8-3.9%) and no ARGs associated with 3rd-generation cephalosporin resistance were detected. By contrast, ampicillin (29.4%, CI 22.8-37.0%), florfenicol (24.3%, CI 17.8-32.3%) and gentamicin (CI 17.5%, 10.7-27.2%) resistance prevalence varied greatly between farms and associated ARGs were common. The most common combined resistance phenotype was ampicillin-florfenicol.
CONCLUSION: The use of registered antimicrobials in Australian pigs leads to the enteric commensal populations acquiring associated ARGs. However, despite a high intensity of sampling, ARGs imparting resistance to the critically important 3rd-generation cephalosporins were not detected.
© 2016 Australian Veterinary Association.

Entities:  

Keywords:  Escherichia coli; antimicrobial resistance; hydrophobic grid-membrane filtration; pigs

Mesh:

Substances:

Year:  2016        PMID: 27671081     DOI: 10.1111/avj.12491

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  4 in total

1.  Shiga toxin-producing Escherichia coli O157 in piglets and food from backyard systems.

Authors:  Gerardo Uriel Bautista-Trujillo; Mayra Isabel Hernández-Hernández; Javier Gutiérrez-Jiménez; Fernando Azpiri-Álvarez; Rene Pinto-Ruiz; Francisco Guevara-Hernández; Benigno Ruiz-Sesma; Paula Mendoza-Nazar; Daniel González-Mendoza
Journal:  Vet Res Forum       Date:  2022-06-15       Impact factor: 0.950

2.  The Antimicrobial Peptide Mastoparan X Protects Against Enterohemorrhagic Escherichia coli O157:H7 Infection, Inhibits Inflammation, and Enhances the Intestinal Epithelial Barrier.

Authors:  Xueqin Zhao; Lei Wang; Chunling Zhu; Xiaojing Xia; Shouping Zhang; Yimin Wang; Huihui Zhang; Yanzhao Xu; Shijun Chen; Jinqing Jiang; Shanqin Liu; Yundi Wu; Xilong Wu; Gaiping Zhang; Yueyu Bai; Hanna Fotina; Jianhe Hu
Journal:  Front Microbiol       Date:  2021-06-10       Impact factor: 5.640

3.  Superbugs in the supermarket? Assessing the rate of contamination with third-generation cephalosporin-resistant gram-negative bacteria in fresh Australian pork and chicken.

Authors:  Jade E McLellan; Joshua I Pitcher; Susan A Ballard; Elizabeth A Grabsch; Jan M Bell; Mary Barton; M Lindsay Grayson
Journal:  Antimicrob Resist Infect Control       Date:  2018-02-23       Impact factor: 4.887

4.  Antimicrobial Susceptibility of Escherichia coli and Salmonella spp. Isolates From Healthy Pigs in Australia: Results of a Pilot National Survey.

Authors:  Amanda K Kidsley; Sam Abraham; Jan M Bell; Mark O'Dea; Tanya J Laird; David Jordan; Pat Mitchell; Christopher A McDevitt; Darren J Trott
Journal:  Front Microbiol       Date:  2018-07-09       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.